|
Secondary Osteoporosis
Citations 1-9 of 9 total displayed.
|
Most recent content
(1 May 2010):
|
- Perspectives
PPAR , an Essential Regulator of Bone Mass: Metabolic and Molecular Cues
- Beata Lecka-Czernik
IBMS BoneKEy 2010; 7: 171-181.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Mar 2001):
|
- Perspectives
Depression, Selective Serotonin Re-Uptake Inhibitors and the Regulation of Bone Mass
- Itai Bab and Raz Yirmiya
IBMS BoneKEy 2009; 6: 8-15.
[Abstract]
[Full text]
[PDF]
- Perspectives
Aromatase Inhibitors and Bone Health
- Eugene V. McCloskey
BoneKEy-Osteovision 2006; 3: 5-13.
[Abstract]
[Full text]
[PDF]
- Perspectives
Celiac Disease: Its Effects on Bone
- Maria L. Bianchi and Maria T. Bardella
BoneKEy-Osteovision 2006; 3: 30-38.
[Abstract]
[Full text]
[PDF]
- Perspectives
11ß-HSD: Guardian or Gate Crasher?
- Robert S. Weinstein
BoneKEy-Osteovision 2005; 2: 6-13.
[Full text]
[PDF]
- Commentaries
Prevention of Drug-Induced Osteoporosis: A New Challenge
- Aurelio Rapado
BoneKEy-Osteovision 2001; 1: 2001045.
[Full text]
- Commentaries
Effects of Inhaled Steroids on Bone Mineral Density: Are the Conclusions Misleading?
- Richard Eastell
BoneKEy-Osteovision 2001; 1: 2001044.
[Full text]
- Commentaries
Glucocorticoid Osteoporosis - Relations to BMU Theory and to Bone Cell Birth
- A. M. Parfitt
BoneKEy-Osteovision 2001; 1: 2001026.
[Full text]
- Commentaries
Death and Taxes: Glucocorticoids and Bone Cell Apoptosis
- Stephen M Krane
BoneKEy-Osteovision 2001; 1: 2001019.
[Full text]
|
|